Results 171 to 180 of about 205,750 (304)
Predictors of disease-free and overall survival in retroperitoneal sarcomas: A modern 16-year multi-institutional study from the United States Sarcoma Collaboration (USSC) [PDF]
al., et +2 more
core +1 more source
ABSTRACT Ovarian cancer (OC) continues to be the deadliest gynecological malignancy and a significant cause of cancer‐related mortality among women worldwide. Standard treatment strategies typically entail platinum‐based chemotherapy in conjunction with cytoreductive surgery.
Zunera Khalid +4 more
wiley +1 more source
Neoadjuvant chemotherapy for high-risk upper tract urothelial cancer. [PDF]
Malshy K, Messing EM.
europepmc +1 more source
ABSTRACT Background Between 2002 and 2013, we performed pancreatoduodenectomy (PD) with combined resection of the superior mesenteric artery (SMA) (PD‐SMAR) to treat locally advanced pancreatic head cancer (PHC). Since 2011, we have performed PD with circumferential lymph node dissection along the SMA (PD‐CLDS), in which we dissected lymph nodes all ...
Isamu Makino +9 more
wiley +1 more source
Neoadjuvant Chemotherapy for Gastric Cancer: Evolving Approaches and Supporting Evidence. [PDF]
Kim YJ, Kim HD, Hyung J, Ryu MH.
europepmc +1 more source
ABSTRACT Background Steatotic liver disease (SLD) is an unrecognized complication after pancreaticoduodenectomy (PD) and may affect nutrition and long‐term recovery. This meta‐analysis estimated the incidence of SLD after PD and identified its clinical and surgical risk factors.
Ronnakorn Kongsakon +4 more
wiley +1 more source
ABSTRACT Background/Purpose Prognostic significance of preoperative patient‐related factors, including oral health status, in pancreatic ductal adenocarcinoma (PDAC) remains unclear. We evaluated the association between preoperative factors—particularly oral health parameters—and long‐term survival after curative PDAC resection.
Kaoru Seo +8 more
wiley +1 more source
Pathological Predictors of Residual Cancer Burden Following Neoadjuvant Chemotherapy in Breast Cancer. [PDF]
Carabas BA, Tapoi D, Costache M.
europepmc +1 more source
Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer
ABSTRACT Background Gallbladder cancers (GBCs) are aggressive tumors with limited improvement in outcomes over decades. Accurate prediction of survival is crucial for tailored treatment and improved outcomes. Objective To develop a nomogram predicting overall survival (OS) in resectable GBCs.
Shraddha Patkar +9 more
wiley +1 more source
A multigene model for response stratification to neoadjuvant chemotherapy in triple negative breast cancer. [PDF]
van den Ende NS +5 more
europepmc +1 more source

